Communiqués Pharmacolog i Uppsala AB

Actions

PERP B

SE0019071812

Marché Fermé - Nasdaq Stockholm Autres places de cotation 15:04:26 04/07/2024			Varia. 5j.	Varia. 1 janv.
0,135 ^SEK	+0,37 %		+0,75 %	+138,52 %

17/05	Perpetua Medical AB (publ) publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
23/04	Pharmacolog i Uppsala AB (publ) changera son symbole boursier de PHLOG B à PERP B	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Perpetua Medical publishes interim report January - March 2024	17/05	AQ
Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) appoints Camilla Lönn as CFO	24/04	AQ
Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company name	23/04	AQ
ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON APRIL 16, 2024	16/04	AQ
Pharmacolog publishes annual report for 2023	16/04	AQ
Nolsterby Invest AB has increased its holding in Pharmacolog	08/04	AQ
Pharmacolog announces the appointment of Anders Hedlund as interim CEO	04/04	AQ
NOTICE TO EXTRAORDINARY GENERAL MEETING IN PHARMACOLOG I UPPSALA AB (PUBL)	14/03	AQ
Pharmacolog provides update on new business direction and proposes name change	14/03	AQ
Pharmacolog announces upcoming change in management	01/03	AQ
Warrants of series TO3 were subscribed to approximately 90.4 percent and Pharmacolog receives approximately SEK 2.3 million	27/02	AQ
Major shareholder in Pharmacolog exercises warrants of series TO3 for at least approximately SEK 0.54 million	20/02	AQ
The last day of trading with warrants of series TO3 in Pharmacolog is today, February 20, 2024	20/02	AQ
Year-end bulletin Pharmacolog 2023	16/02	AQ
Pharmacolog investigates the possibilities for a new business direction	15/02	AQ
Pharmacolog terminates the partnership agreement with Codonics with immediate effect	14/02	AQ
Pharmacolog divests part of its operations to RaySearch Laboratories AB	09/02	AQ
The exercise period for warrants of series TO3 begins today	09/02	AQ
The subscription price for the exercise of warrants of series TO3 in Pharmacolog has been set at SEK 0.054 per share	08/02	AQ
Inova Healthcare selects WasteLog™	10/01	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Pharmacolog i Uppsala AB

Actions

PERP B

SE0019071812

Communiqués

Filtres